FLUDARABINE Safety Questions, FLUDARABINE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about FLUDARABINE. Our extensive database of FLUDARABINE adverse events and FLUDARABINE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about FLUDARABINE
FLUDARABINE Safety Reports
Total FLUDARABINE reports: 160.FLUDARABINE FDA safety alerts: No.
Reported deaths: 41 Reported hospitalizations: 87.
Take FLUDARABINE Side Effects Survey or Share Your FLUDARABINE Story. Read More Here.
Showing 1-75 of 160 Next >
Health Professional from UNITED STATES reported FLUDARABINE problem on Aug 11, 2006. Male patient, weighting 104.1 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood pressure decreased, body temperature increased, chronic obstructive pulmonary disease, hypoventilation, loss of consciousness, lung hyperinflation, staphylococcal infection. FLUDARABINE dosage: 48 MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN, PROGRAF, PREVACID, ZOFRAN, AVELOX, VOIROCNAZOLES, IMIPENEN. Patient was hospitalized. Patient recovered.FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 11, 2006. Female patient, weighting 154.3 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: respiratory distress. FLUDARABINE dosage: 45 MG DAILY IV DRIP. During the same period patient was treated with MELPHALAN, CAMPATH. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from AUSTRALIA reported FLUDARABINE problem on July 26, 2006. Male patient, 45 years of age, weighting 183.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: migraine. FLUDARABINE dosage: 47.5 MG/DAY, 5 CYCLES X 3 DAYS, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, METOCLOPRAMIDE, CYCLIZINE, DOLASETRON, PANADENE. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Male patient, 58 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: retinal haemorrhage. FLUDARABINE dosage: 30 MG/M2, DAYS 2-3. During the same period patient was treated with CYTARABINE, RITUXAN, OXALIPLATIN, COMPAZINE, DARVON, PROTONIX, HUMULIN, VALTREX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported FLUDARABINE problem on Aug 21, 2006. Male patient, weighting 169.8 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, chest x-ray abnormal, headache, neutropenia. FLUDARABINE dosage: 240 MG. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from FRANCE on Aug 08, 2006. Female patient, 66 years of age, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, cytolytic hepatitis, gamma-glutamyltransferase increased, jaundice, liver disorder. FLUDARABINE dosage: 40 MG/M2, INTRAVENOUS. During the same period patient was treated with NEURONTIN, MONICOR L, COKENZEN, LEVOTHYROXINE, PLAVIX, LANTUS. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Aug 28, 2006. Male patient, 58 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: diabetic complication, hypertension, retinal haemorrhage. FLUDARABINE dosage: unknown. During the same period patient was treated with OXALIPLATIN, RITUXIMAB, CYTARABINE, LEVOFLOXACIN, SULFAMETHOXAZOLE, VORICONAZOLE, VALACYCLOVIR, HUMULIN. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Sept 11, 2006. Female patient, weighting 124.3 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: aggression, delirium. FLUDARABINE dosage: 42MG ONCE A DAY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN, PROGRAF, PREVACID, REMERON, METOPROLOL, DAPSONE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Sept 14, 2006. Male patient, 60 years of age, weighting 190.7 lb, was diagnosed with myelodysplastic syndrome and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, dyspnoea, stem cell transplant. FLUDARABINE dosage: 71MG IV QD. During the same period patient was treated with CYTOXAN, CLOTRIMAZOLE, URSODIOL, FOLIC ACID, LANSOPRAZOLE, TAMSULOSIN, LEUKINE. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Sept 18, 2006. Male patient, weighting 167.6 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, bk virus infection, blood creatinine increased, clostridial infection. FLUDARABINE dosage: unknown. During the same period patient was treated with CAMPATH, BUSULFAN, PROGRAF, LOVENOX, ORAL AND IV VANCOMYCIN, VORICONAZOLE, DAPTOMYCIN, CIFOFAVIR. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Sept 19, 2006. Female patient, 79 years of age, weighting 105.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: malignant melanoma. FLUDARABINE dosage: unknown. During the same period patient was treated with RITUXAN. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from GERMANY on Sept 08, 2006. Female patient, 59 years of age, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: catheter related infection, fall, graft versus host disease, proteus infection, retroperitoneal haematoma, syncope vasovagal, thrombosis. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported FLUDARABINE problem on Sept 20, 2006. Female patient, 68 years of age, weighting 156.5 lb, was diagnosed with chronic lymphocytic leukaemia, small cell carcinoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, dizziness, hypoaesthesia, neuropathy peripheral, nuclear magnetic resonance imaging abnormal, nystagmus, urinary tract infection. FLUDARABINE dosage: unknown. During the same period patient was treated with SYNTHROID, TYLENOL, KEFLEX, ACYLOVIR, PROTONIX, BENADRYL, PREDNISONE. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Sept 25, 2006. Female patient, 66 years of age, weighting 322.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased. FLUDARABINE dosage: 44 MG X 3 DAYS IV. During the same period patient was treated with CYTOXAN. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Sept 27, 2006. Male patient, 60 years of age, weighting 190.7 lb, was diagnosed with myelodysplastic syndrome and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: neutrophil count abnormal, platelet count abnormal, stem cell transplant, transplant failure. FLUDARABINE dosage: 71MG IV QD. During the same period patient was treated with CYTOXAN, UMBILICAL CORD BLOOD, NEUPOGEN, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, ACYCLOVIR, CASPOFUNGIN. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Sept 27, 2006. Female patient, weighting 141.1 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: folliculitis, headache, rash. FLUDARABINE dosage: unknown. During the same period patient was treated with CAMPAT, MELPHALAN, PROGRAF, DIFLUCAN, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Health Professional from AUSTRALIA reported FLUDARABINE problem on Sept 11, 2006. Male patient, 45 years of age, weighting 183.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: migraine. FLUDARABINE dosage: SEE IMGAE. During the same period patient was treated with CYCLOPHOSPHAMIDE, METOCLOPRAMIDE, CYCLIZINE, DOLASETRON, PANADENE. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Male patient, 58 years of age, was diagnosed with chronic lymphocytic leukaemia transformation and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: hypertension, retinal detachment, retinal haemorrhage, retinal ischaemia. FLUDARABINE dosage: 30 MG/M2, DAYS 2-3. During the same period patient was treated with CYTARABINE, RITUXAN, OXALIPLATIN, COMPAZINE, DARVON, PROTONIX, HUMULIN, VALTREX. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Oct 11, 2006. Male patient, weighting 160.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: back pain, blood culture positive, constipation, hepatic enzyme increased, infection, intervertebral discitis, osteomyelitis. FLUDARABINE dosage: 57MG DAILY IV. During the same period patient was treated with MELPHALAN, CAMPATH, PROGRAF, VALTREX, DILAUDID. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Oct 11, 2006. Male patient, weighting 286.6 lb, was diagnosed with leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: chills, clostridial infection, diarrhoea, eosinophilia, graft versus host disease, nausea, pyrexia, rash. FLUDARABINE dosage: 72MG DAILY IV. During the same period patient was treated with MELPHALAN, CAMPATH, PREVACID, DIFLUCAN, VALTREX, PROGRAF, PRINIVOL, BACTIRM. Patient was hospitalized. Patient recovered.
Health Professional from RUSSIAN FEDERATION reported FLUDARABINE problem on Sept 28, 2006. Male patient, 75 years of age, weighting 167.6 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute sinusitis, adhesion, alanine aminotransferase increased, angiopathy, angiosclerosis, aortic arteriosclerosis, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased. FLUDARABINE dosage: 40 MG/M2, CYCLE X 5D, EVERY 28 D, ORAL. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from GERMANY on Sept 29, 2006. Male patient, 80 years of age, weighting 152.1 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, diarrhoea, insomnia, nausea, oedema peripheral, platelet count decreased, pleural effusion, pulmonary hypertension. FLUDARABINE dosage: unknown. Patient recovered.
Health Professional from GERMANY reported FLUDARABINE problem on Sept 29, 2006. Male patient, 73 years of age, weighting 218.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, fatigue, leukopenia, renal failure. FLUDARABINE dosage: unknown. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Nov 01, 2006. Female patient, weighting 121.0 lb, was diagnosed with haematopoietic stem cell mobilisation, stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood test abnormal, fatigue, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased. FLUDARABINE dosage: 48 MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 01, 2006. Male patient, weighting 163.4 lb, was diagnosed with lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: aspiration, blood culture positive, heart rate increased, infection, pharyngolaryngeal pain, productive cough, respiratory rate increased, sputum discoloured, staphylococcal infection. FLUDARABINE dosage: 57 MG DAILY IV. During the same period patient was treated with MELPHAAN, CAMPATH. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Nov 08, 2006. Male patient, weighting 271.2 lb, was diagnosed with leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, deep vein thrombosis, dizziness, hypoxia, pulmonary embolism, syncope, unresponsive to stimuli. FLUDARABINE dosage: 72MG DAILY IV. During the same period patient was treated with MELPHLAN, CAMPAHT, PREDNISONE, PREVACID, VALTREX, DIFLUCAN. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 08, 2006. Male patient, weighting 231.5 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: culture urine positive, dysuria, pyrexia. FLUDARABINE dosage: 70MG ONCE A DAY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Physician from UNITED STATES on Oct 23, 2006. Male patient, 59 years of age, was diagnosed with stem cell transplant, prophylaxis against transplant rejection, immunosuppression and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, atrial fibrillation, blood stem cell transplant failure, cholangitis, fungal infection, gastrointestinal haemorrhage, hepatic encephalopathy. FLUDARABINE dosage: 30MG/M2 DAYS -4, -3, -2, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient died on 10/18/2006.
Health Professional from GERMANY reported FLUDARABINE problem on Oct 23, 2006. Male patient, 73 years of age, weighting 218.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, condition aggravated, fatigue, hepatomegaly, leukopenia, renal failure, splenomegaly. FLUDARABINE dosage: 25 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, METOPROLOL SUCCINATE, METFORMIN. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Nov 14, 2006. Male patient, weighting 357.8 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: culture urine positive. FLUDARABINE dosage: 70MG ONCE A DAY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN, PEPCID, ALLOPURINOL, ZOCOR, VALTREX. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 20, 2006. Female patient, 63 years of age, weighting 148.0 lb, was diagnosed with acute myeloid leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: anaemia, angina pectoris, chest discomfort, gastritis, oesophagitis. FLUDARABINE dosage: 24 MG OVER 30 MIN DAILY X 5DAYS IV. During the same period patient was treated with CARBOPLATIN, TOPOTECAN, THALIDOMIDE. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Pharmacist from UNITED STATES on Nov 22, 2006. Male patient, 63 years of age, weighting 330.7 lb, was diagnosed with bone marrow transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: amnesia, computerised tomogram abnormal, cough, lung infiltration, mental status changes, nervous system disorder, nuclear magnetic resonance imaging brain abnormal, oxygen saturation decreased. FLUDARABINE dosage: 68 MG DAILY X 4 DOSES IV. During the same period patient was treated with CAMPATH, LANTUS, FLUCONAZOLE, METOPROLOL SUCCINATE, DILTIAZEM, NEXIUM, ALLOPURINOL, TYLENOL. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 29, 2006. Male patient, weighting 163.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, cholelithiasis, constipation. FLUDARABINE dosage: 57MG DAILY IV. During the same period patient was treated with MELPHALAN, CAMPATH. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Nov 29, 2006. Female patient, 63 years of age, weighting 148.0 lb, was diagnosed with acute myeloid leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: aplasia, blood albumin decreased, hypoglycaemia, platelet count decreased, white blood cell count decreased. FLUDARABINE dosage: 24 MG OVER 30 MIN PER DAY X 5D IV. During the same period patient was treated with CARBOPLATIN, TOPOTECAN, THALIDOMIDE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Nov 29, 2006. Male patient, weighting 141.1 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, dysuria, pyrexia. FLUDARABINE dosage: 50MG ONCE A DAY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Female patient, 40 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, refractory anaemia with an excess of blasts. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.
Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Female patient, 60 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Male patient, 65 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: lymphoma, malignant neoplasm progression, myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.
Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Female patient, 66 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, neutropenic sepsis, pancytopenia. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, MITOXANTRONE. Patient died.
FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Female patient, 53 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, CARMUSTINE, CYTARABINE, MELPHALAN. Patient recovered.
Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Male patient, 53 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chronic myelomonocytic leukaemia, malignant neoplasm progression. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, MITOXANTRONE. Patient died.
FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Male patient, 56 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Female patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, refractory anaemia with an excess of blasts. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB. Patient died.
FLUDARABINE problem was reported by a Physician from AUSTRALIA on Nov 10, 2006. Female patient, 52 years of age, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: disease progression, myelodysplastic syndrome, refractory anaemia with an excess of blasts. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, MITOXANTRONE. Patient died.
Physician from AUSTRALIA reported FLUDARABINE problem on Nov 10, 2006. Male patient, 69 years of age, was diagnosed with follicle centre lymphoma, follicular grade i, ii, iii and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: lymphoma, malignant neoplasm progression, myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB. Patient died.
FLUDARABINE problem was reported by a Physician from ITALY on Nov 23, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CHLORAMBUCIL. Patient recovered.
Physician from ITALY reported FLUDARABINE problem on Nov 23, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CHLORAMBUCIL. Patient recovered.
FLUDARABINE problem was reported by a Physician from ITALY on Nov 23, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CHLORAMBUCIL. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Dec 20, 2006. Female patient, 63 years of age, weighting 148.0 lb, was diagnosed with acute myeloid leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, neutropenia, platelet count abnormal, white blood cell count decreased. FLUDARABINE dosage: 24 MG OVER 30 MIN. DAILY X 5 D IV. During the same period patient was treated with CARBOPLATIN, TOPOTECAN, THALIDOMIDE. Patient died on 12/15/2006.
FLUDARABINE problem was reported by a Physician from RUSSIAN FEDERATION on Dec 04, 2006. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cardiac failure acute, renal failure acute, tumour lysis syndrome. FLUDARABINE dosage: unknown. Patient died on 12/02/2006.
Physician from UNITED STATES reported FLUDARABINE problem on Oct 16, 2006. Female patient, 78 years of age, weighting 141.1 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, bilirubin conjugated increased, blood bilirubin increased, blood creatinine increased, blood glucose decreased, blood glucose increased, blood lactate dehydrogenase increased, bone marrow failure, cardiovascular insufficiency. FLUDARABINE dosage: unknown. Patient died on 10/14/2006.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Dec 15, 2006. Female patient, 53 years of age, weighting 185.2 lb, was diagnosed with antiviral prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: pericarditis, pyelonephritis acute. FLUDARABINE dosage: unknown. During the same period patient was treated with MABCAMPATH, COTRIM D, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported FLUDARABINE problem on Apr 11, 2007. Male patient, 72 years of age, was diagnosed with constipation, palliative care and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: ascites. FLUDARABINE dosage: 40 MG QD X 5. During the same period patient was treated with TRIMEBUTINE, FUROSEMIDE, LAEVOLAC EPS, PREDNISONE. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on May 15, 2007. Male patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood potassium increased, blood urea increased, gallbladder disorder, haematocrit decreased, haemoglobin decreased, nausea, platelet count decreased. FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULFAN, CAMPATH. Patient died on 05/11/2007.
Consumer or non-health professional from UNITED STATES reported FLUDARABINE problem on July 02, 2007. Male patient, weighting 147.0 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, herpes zoster, methicillin-resistant staphylococcal aureus test positive, urinary tract infection staphylococcal. FLUDARABINE dosage: 225 MG. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Physician from UNITED KINGDOM on July 03, 2007. Female patient, 45 years of age, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: sarcoidosis. FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULPHAN, PENICILLIN V, ACYCLOVIR, CAMPATH. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on July 10, 2007. Male patient, weighting 168.4 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: gait disturbance, visual disturbance. FLUDARABINE dosage: 53MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN, PORGRAF, ACTIGALL, DIFLUCAN, VALTREX, BACTRIM. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Male patient, weighting 183.0 lb, was diagnosed with acute myeloid leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: hypoxia, pulmonary embolism, pyrexia. FLUDARABINE dosage: unknown. During the same period patient was treated with MELPHALAN, CAMPATH. Patient recovered.
Physician from UNITED KINGDOM reported FLUDARABINE problem on July 12, 2007. Male patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: petit mal epilepsy. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
FLUDARABINE problem was reported by a Pharmacist from UNITED STATES on July 17, 2007. Male patient, 45 years of age, weighting 152.3 lb, was diagnosed with bone marrow transplant, myelofibrosis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: brain natriuretic peptide increased, cardiac failure congestive, ejection fraction decreased. FLUDARABINE dosage: 60MG INFUSED OVER 30 MI IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported FLUDARABINE problem on July 18, 2007. Male patient, 72 years of age, weighting 121.3 lb, was diagnosed with constipation, palliative care and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant. FLUDARABINE dosage: 40 MG QD X 5. During the same period patient was treated with TRIMEBUTINE, FUROSEMIDE, LAEVOLAC EPS, PREDNISONE, FENTANYL TRANSDERMAL SYSTEM, OXALIPLATIN. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on July 31, 2007. Female patient, weighting 120.6 lb, was diagnosed with bone marrow conditioning regimen, stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia. FLUDARABINE dosage: 54 MG DAILY IV DRIP. During the same period patient was treated with FLUDARABINE PHOSPHATE, THIOTEPA. Patient was hospitalized. Patient recovered.
Health Professional from UNITED STATES reported FLUDARABINE problem on Aug 07, 2007. Female patient, weighting 133.2 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: hypotension, ill-defined disorder, pyrexia. FLUDARABINE dosage: 54MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Female patient was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia, fatigue. FLUDARABINE dosage: 54 MG DAILY IV DRIP. During the same period patient was treated with THIOTEPA. Patient died on 08/02/2007.
Physician from UNITED STATES reported FLUDARABINE problem on Aug 07, 2007. Male patient, 72 years of age, weighting 121.3 lb, was diagnosed with constipation, palliative care and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant. FLUDARABINE dosage: 40 MG QD X 5. During the same period patient was treated with TRIMEBUTINE, FUROSEMIDE, LAEVOLAC EPS, PREDNISONE, FENTANYL, OXALIPLATIN. Patient was hospitalized. Patient died on 07/26/2007.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 15, 2007. Male patient was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, jc virus infection, progressive multifocal leukoencephalopathy. FLUDARABINE dosage: 53 MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, BUSULFAN. Patient died on 08/11/2007.
Health Professional from UNITED KINGDOM reported FLUDARABINE problem on May 21, 2007. Male patient, weighting 192.9 lb, was diagnosed with b-cell lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: ascites, constipation, deep vein thrombosis, febrile neutropenia, intestinal obstruction, white blood cell count decreased. FLUDARABINE dosage: unknown. During the same period patient was treated with NOVANTRONE, ALLOPURINOL, DEXAMETHASONE, PARACETAMOL, SPIRONOLACTONE, SULFAMETHOXAZOLE. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, weighting 159.8 lb, was diagnosed with stem cell transplant and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, escherichia infection, hypotension, infusion related reaction, pyrexia, stem cell transplant, tachycardia. FLUDARABINE dosage: 50 MG DAILY IV DRIP. During the same period patient was treated with THIOTEPA. Patient was hospitalized. Patient recovered.
Health Professional from RUSSIAN FEDERATION reported FLUDARABINE problem on Aug 17, 2007. Male patient, 55 years of age, weighting 143.3 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, thrombocytopenia. FLUDARABINE dosage: 42.5 MG, 1X/DAY. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died on 12/30/2006.
FLUDARABINE problem was reported by a Physician from UNITED KINGDOM on Aug 10, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia, prophylaxis and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: coronary artery thrombosis. FLUDARABINE dosage: 25 MG/M2, 1X/DAY. During the same period patient was treated with COTRIM, CYCLOPHOSPHAMIDE. Patient died.
Physician from AUSTRIA reported FLUDARABINE problem on Aug 22, 2007. Male patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: pemphigus. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB. Patient was hospitalized. Patient recovered.
FLUDARABINE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 73 years of age, was treated with FLUDARABINE. FLUDARABINE dosage: unknown. During the same period patient was treated with CAMPATH. Patient died on 04/28/2007.
Physician from AUSTRIA reported FLUDARABINE problem on Aug 24, 2007. Male patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: pemphigus. FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB. Patient recovered.
FLUDARABINE problem was reported by a Physician from UNITED STATES on Aug 24, 2007. Female patient, 53 years of age, weighting 185.2 lb, was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: pericardial effusion. FLUDARABINE dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CAMPATH, COTRIM. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported FLUDARABINE problem on Sept 04, 2007. Male patient, 68 years of age, weighting 243.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, bone marrow failure, fungal infection, hypoacusis, mental status changes, myalgia, pancytopenia, respiratory distress. FLUDARABINE dosage: 60MG QD X 3;Q28D IV. Patient was hospitalized. Patient died on 08/05/2007.
Showing 1-75 of 160 Next >
This
drug has an active FDA Safety Alert